Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Dec 1;14:2633494120964517. doi: 10.1177/2633494120964517

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s), 2020

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 2. — Mean change from baseline to month 6 in the PROMIS Fatigue Questionnaire T-scores in patients receiving elagolix 150 mg once daily or 200 mg twice daily or placebo in EM-I.³⁹ N values (placebo/elagolix 150 mg once daily/elagolix 200 mg twice daily): month 1: 348/224/219; month 3: 314/216/198; month 6: 246/170/161. The mean difference from placebo is indicated for p < 0.05 (*), p < 0.01 (**), p < 0.001 (***).

Source: Reprinted from Surrey and colleagues,³⁹ Copyright © 2019, with permission from Elsevier.

BID, twice daily; LS, least squares; PROMIS, Patient-Reported Outcomes Measurement Information System, QD, once daily; SE, standard error.